//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Commonwealth legislation
This Act has been repealed and is no longer in force. It is retained for historical reference.
This instrument updates the Pharmaceutical Benefits Scheme price list, replacing the November 2005 schedule and taking effect 1 February 2006. It names hundreds of prescription medicines with specified brands, strengths, pack sizes, permitted supply quantities, and two prices per item (manufacturer’s price for subsidy calculation and the manufacturer‑claimed price). A transitional rule preserves old prices for six listed medicines when prescribed before 1 August 2005 and supplied before 1 March 2006. It affects manufacturers, pharmacists, and patients; manufacturer codes are provided.
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in National Health Act 1953 - Determination under subsection 85B(1) (No. PB 5 of 2006).
Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
COMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DETERMINATION UNDER SUBSECTION 85B(1)
No. PB 5 of 2006
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to subsection 85B(1) of the National Health Act 1953 (referred to in this Determination as “the Act”), hereby make the following Determination:
This Determination commences on 1 February 2006.
Determination No. PB 33 of 2005 under subsection 85B(1) of the National Health Act 1953, made on 23 November 2005 with effect from 1 December 2005, is repealed.
In this Determination “authority prescription” means a prescription which directs the supply of a pharmaceutical benefit and is a prescription authorised in accordance with paragraph 12 of the determinations made under sections 85, 85A and 88 of the Act.
Section 85B of the Act applies in relation to each of the brands of the pharmaceutical benefits specified in Part A of the Schedule to this Determination (referred to in this Determination as “the Schedule”).
For the purposes of paragraph 85B(1)(c) of the Act, the quantity or number of units that is relevant for the purpose of determining an amount referred to in paragraph 85B (1) (d) or 85B(1)(e) of the Act in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the quantity or number of units specified in Part B of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(d) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part C of the Schedule in relation to the brand of the pharmaceutical benefit.
For the purposes of paragraph 85B(1)(e) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the price claimed by the manufacturer as the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part D of the Schedule in relation to the brand of the pharmaceutical benefit.
Notwithstanding anything else in this Determination, section 85B of the Act will not apply in respect of the pharmaceutical benefits listed in the following table if the prescription which directs the supply of the pharmaceutical benefit was written before 1 August 2005 and supply is made before 1 March 2006:
| Drug or medicinal preparations | Form (strength, type, size, etc) | Brand |
|---|---|---|
| Escitalopram Oxalate | Tablet equivalent to 10 mg escitalopram | LU |
| Tablet equivalent to 20 mg escitalopram | LU | |
| Levetiracetam | Tablet 250 mg | UC |
| Tablet 500 mg | UC | |
| Tablet 1 g | UC | |
| Pemetrexed Disodium Heptahydrate | Powder for I.V. infusion equivalent to 500 mg pemetrexed, vial | LY |
| Topiramate | Tablet 25 mg | JC |
| Tablet 50 mg | JC | |
| Tablet 100 mg | JC | |
| Tablet 200 mg | JC | |
| Capsule 15 mg | JC | |
| Capsule 25 mg | JC | |
| Capsule 50 mg | JC |
| Letters | Manufacturer's Name | Letters | Manufacturer's Name |
|---|
| AB | Abbott Australasia Pty Ltd |
|---|---|
| AD | Amrad Pharmaceuticals Pty Ltd |
| AG | Allergan Australia Pty Ltd |
| AL | Alphapharm Medical A Division of Alphapharm Pty Limited |
| AP | AstraZeneca Pty Ltd |
| AQ | Alcon Laboratories (Australia) Pty Ltd |
| AS | Aspen Pharmacare Australia Pty Ltd |
| AV | Aventis Pharma Pty Limited |
| BN | Bayer Australia Limited |
| BP | British Pharmaceuticals |
| BQ | Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd |
| BX | Baxter Healthcare Pty Limited |
| BY | Boehringer Ingelheim Pty Limited |
| CS | CSL Limited |
| FR | Charles E. Frosst Division of Merck Sharp & Dohme (Australia) Pty Ltd |
| GC | GlaxoSmithKline Consumer Healthcare |
| GK | GlaxoSmithKline Australia Pty Ltd |
| HX | Hexal Australia Pty Ltd |
| JC | Janssen-Cilag Pty Ltd |
| KN | Knoll A Division of Abbott Australasia Pty Ltd |
| LU | Lundbeck Australia Pty Ltd |
| LY | Eli Lilly Australia Pty Limited |
| MK | Merck Sharp & Dohme (Australia) Pty Ltd |
| MM | 3M Pharmaceuticals Australia Pty Ltd |
| MQ | Merck Pharmaceuticals |
| MX | Mayne Pharma Pty Ltd |
| NV | Novartis Pharmaceuticals Australia Pty Ltd |
| OR | Organon (Australia) Pty Limited |
| PC | Pfizer Consumer Healthcare Pty Ltd |
| PF | Pfizer Pty Limited |
| PH | Pharmacia Australia Pty Limited |
| RO | Roche Products Pty Ltd |
| SC | Schering Pty Ltd Australian Subsidiary of Schering AG, Berlin |
| SE | Servier Laboratories (Aust.) Pty Ltd |
| SG | Serono Australia Pty Ltd |
| SI | Sigma Pharmaceuticals Pty Ltd |
| SM | Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd |
| SU | Sauter Laboratories (Aust.) Pty Ltd |
| SW | Sanofi-Synthelabo Australia Pty Limited |
| SZ | Sandoz Pty Ltd |
| UC | UCB Pharma A Division of UCB Australia Pty Ltd |
| VT | Valeant Pharmaceuticals Australasia Pty Ltd |
| WY | Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited |
<table cellspacing="0" cellpadding="0" style="margin-top:0pt; margin-bottom:0pt; border-collapse:collapse"><tbody><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><a id="bmk85Bs1"><span>Aciclovir</span></a></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 200</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>25</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>45.17</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>47.80</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>90</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>165.31</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>169.20</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 800</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>35</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>200.27</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>202.36</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>GK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>120</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>664.38</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>671.30</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Alendronate Sodium</span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet equivalent to 70</span><span> </span><span>mg alendronic acid</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>MK</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>4</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>45.19</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>45.41</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Allopurinol</span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 100</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>SI</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>200</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>8.11</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>10.32</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span></span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 300</span><span> </span><span>mg</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>SI</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>60</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>4.80</span></p></td><td style="width:42.65pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>6.87</span></p></td></tr><tr><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Alprazolam</span></p></td><td style="width:104.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTable"><span>Tablet 250</span><span> </span><span>micrograms</span></p></td><td style="width:48.2pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>PH</span></p></td><td style="width:36.9pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>50</span></p></td><td style="width:42.55pt; padding-right:1.4pt; padding-left:1.4pt; vertical-align:top"><p class="tTableC"><span>3.74</span></p></td><td style="width:42.65pt; paddin
This is an opening excerpt, not the complete document.